Updated:
Leadenhall Capital Partners
Leadenhall Capital Partners launched in 2008 as a joint venture between Amlin, a global specialty reinsurer, and its founding management team.
Leadenhall Capital Partners
Leadenhall Capital Partners launched in 2008 as a joint venture between Amlin, a global specialty reinsurer, and its founding management team. Amlin was acquired by the MS&AD Group in 2016, and today Mitsui Sumitomo Insurance — an MS&AD subsidiary — holds the strategic stake in the firm (per firm website). The firm allocates capital across three insurance-linked pillars: Life Insurance Linked Strategies (mortality, morbidity, and lapse risks); Non-Life Insurance Linked Strategies through private placements and catastrophe bonds covering natural catastrophes, marine risk, and other specialty products; and Alternative Private Credit, which provides financing to life, health, and non-life entities. Confirmed geographies include global markets with dedicated business development for Japan and Asia. The team draws on 250+ years of combined insurance and capital markets experience from major financial institutions, reinsurers, and Lloyd's. Leadenhall's partnership includes founding Chairman John Wells and CEO Luca Albertini, along with Deputy CEO Lorenzo Volpi, a chief underwriting officer for non-life, and a head of life and alternative credit portfolio management. In January 2026, the firm appointed Yuko Hoshino (Japan and Asia business development) and Anthony Mensa-Bonsu (managing director, non-life) to its partnership (per firm website, January 2026). Additional offices are not disclosed beyond the Greenwich, London headquarters. The firm maintains a structural differentiator in its long-standing relationship with Mitsui Sumitomo Insurance, a Japanese insurer listed as a Nikkei 225 component. This ownership anchor supplies steady capital and underwriting expertise while allowing Leadenhall to operate independently as an FCA, SEC, and BMA regulated asset manager focused exclusively on insurance-linked risk.
General information
Firm type
Asset Manager
Year founded
2008
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Greenwich
Corporate office
Greenwich, London, United Kingdom
Principals
John Wells
Chairman (Founding Partner)
Luca Albertini
Chief Executive Officer (Founding Partner)
Lorenzo Volpi
Deputy Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Leadenhall Capital Partners?
Luca Albertini serves as Chief Executive Officer and Founding Partner. He leads the firm alongside Chairman John Wells, another founding partner. The partnership includes 14 named professionals, with roles covering portfolio management, origination, risk, and compliance. The firm's partnership structure was expanded in January 2026 with two new appointments (per firm website).
How is Leadenhall Capital Partners structured—is it a family office or an asset manager?
Leadenhall is structured as a global asset management firm, not a family office. It is registered with the FCA, SEC, and BMA and offers dedicated funds and tailored managed accounts to institutional investors. The firm was originally a joint venture with Amlin and today has Mitsui Sumitomo Insurance, a subsidiary of the MS&AD Group, as a strategic partner.
What types of insurance-linked strategies does Leadenhall invest in?
Leadenhall allocates across three categories: Life Insurance Linked Strategies (including mortality, morbidity, and lapse risk); Non-Life Insurance Linked Strategies (catastrophe bonds and private placements covering property, marine, and specialty risks); and Alternative Private Credit (financing to life, health, and non-life insurers). The firm emphasizes that these strategies have historically shown low correlation to broader financial markets.
Does Leadenhall Capital Partners participate in fund commitments or only direct deals?
Leadenhall provides both dedicated funds and tailored managed accounts, meaning it operates through pooled vehicles as well as custom mandates for institutional investors. The firm's non-life strategies include both private placements and cat bonds, indicating a mix of direct and market-traded exposures.
What is Leadenhall's relationship with Mitsui Sumitomo Insurance?
Mitsui Sumitomo Insurance, a subsidiary of the MS&AD Group, holds the strategic stake originally owned by Amlin. This relationship provides capital and underwriting support while allowing Leadenhall to operate as an independent asset manager. The firm notes that this structure enables cooperation with various MSI Group entities, including MS Amlin.
Where does the underlying wealth for Leadenhall come from?
Leadenhall does not disclose a specific wealth origin; it is not structured as a family office managing a single fortune. The firm was founded by insurance and capital markets professionals and is backed institutionally by Mitsui Sumitomo Insurance. The underlying capital is primarily from institutional investors, including pension funds and insurers, that allocate to its insurance-linked strategies.
Does Leadenhall maintain philanthropic structures?
There is no public disclosure of a separate philanthropic foundation or charitable arm. The firm's website focuses solely on its investment strategies and partnership. ESG is noted through a Chief Underwriting Officer (Non-Life) who also serves as Head of ESG, but no independent charitable vehicle is mentioned.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: